Adam B. Keeton
Research Assistant Professor
Oncologic Sciences
Mitchell Cancer Institute
United States of America
Biography
Dr. Adam B. Keeton is currently working as Assistant Professor at Department of Oncologic Sciences, Mitchell Cancer Institute USA. He has received his Bachelors in Natural Sciences from University of Alabama at Birmingham . Dr.Adam B. Keeton has received his Ph.D in Pathology from University of Alabama at Birmingham. He serves as membership of 3 scientific society. Dr. Adam B. Keeton selected publications.
Research Interest
Pathology
Publications
-
Keeton AB, Bortoff KD, Bennett WL, Franklin JL, Venable DY, Messina JL. Insulin-regulated expression of Egr-1 and Krox20: dependence on ERK1/2 and interaction with p38 and PI3-kinase pathways. Endocrinology. 2003 Dec 1;144(12):5402-10.
-
Keeton AB, Bortoff KD, Bennett WL, Franklin JL, Venable DY, Messina JL. Insulin-regulated expression of Egr-1 and Krox20: dependence on ERK1/2 and interaction with p38 and PI3-kinase pathways. Endocrinology. 2003 Dec 1;144(12):5402-10.
-
Piazza GA, Keeton AB, Tinsley HN, Gary BD, Whitt JD, Mathew B, Thaiparambil J, Coward L, Gorman G, Li Y, Sani B. A novel sulindac derivative that does not inhibit cyclooxygenases but potently inhibits colon tumor cell growth and induces apoptosis with antitumor activity. Cancer Prevention Research. 2009 Jun 1;2(6):572-80.
-
Tinsley HN, Gary BD, Keeton AB, Zhang W, Abadi AH, Reynolds RC, Piazza GA. Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G. Molecular cancer therapeutics. 2009 Dec 1;8(12):3331-40.
